Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Search Results Details (59)

SortShow
Name Institution Why
David Michael Dorfman, M.D.,Ph.D.Brigham and Women's Hospital Why?
Eric David Jacobsen, M.D.Dana-Farber Cancer Institute Why?
Oreofe Olukemi Odejide, M.D.Dana-Farber Cancer Institute Why?
David Marc Weinstock, M.D.Dana-Farber Cancer Institute Why?
Jochen Klaus Maria Lennerz, Ph.D., M.D.Massachusetts General Hospital Why?
Jorge Castillo, M.D.Dana-Farber Cancer Institute Why?
Nancy Lee Harris, M.D.Massachusetts General Hospital Why?
Nancy Berliner, M.D.Brigham and Women's Hospital Why?
Gordon James Freeman, Ph.D.Dana-Farber Cancer Institute Why?
Judith Ann Ferry, M.D.Massachusetts General Hospital Why?
Tayla B. Heavican, Ph.D.Dana-Farber Cancer Institute Why?
Scott J. Rodig, Ph.D., M.D.Brigham and Women's Hospital Why?
Ellen Martha Gravallese, M.D.Brigham and Women's Hospital Why?
Simon Marc Helfgott, M.D.,C.M.Brigham and Women's Hospital Why?
Ephraim Paul Hochberg, M.D.Massachusetts General Hospital Why?
Per Page    Page  of 4last Nextnext
Prev
Search Criteria
  • Immunoblastic Lymphadenopathy
Click "Why?" to see why a person matched the search.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.